<Disease><Name>SMITH-LEMLI-OPITZ SYNDROME (SLOS)</Name><Synonym>SLOS</Synonym><OMIM><Number>270400</Number><URL>http://omim.org/entry/270400</URL></OMIM><Orphanet><Number>818</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=818</URL></Orphanet><Protein><Number>7-dehydrocholesterol reductase</Number><URL>http://www.uniprot.org/uniprot/Q9UBM7</URL></Protein><ExPASy><Number>1.3.1.21</Number><URL>http://enzyme.expasy.org/EC/1.3.1.21</URL></ExPASy><Gene>11q13.4</Gene><ICD>Q87.1</ICD><Summary>rare (1:10000 - 1:60000);autosomal recessive ;type I : milder form ;type II: more severe form</Summary><Symptoms><symtomp><id>1803</id><symptom>anteverted nostril</symptom><category>HEAD</category></symtomp><symtomp><id>3801</id><symptom>behavior, aggressive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1952</id><symptom>behavior, self-mutilating or destructive / behaviour, self-mutilating or destructive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1829</id><symptom>broad chin or mandible</symptom><category>HEAD</category></symtomp><symtomp><id>1767</id><symptom>broad forehead (wide)</symptom><category>HEAD</category></symtomp><symtomp><id>2413</id><symptom>broad nasal bridge</symptom><category>HEAD</category></symtomp><symtomp><id>3158</id><symptom>cardiac involvement, defects or anomalies</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2257</id><symptom>cholestasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2321</id><symptom>cleft palate</symptom><category>HEAD</category></symtomp><symtomp><id>3377</id><symptom>clubfoot</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1720</id><symptom>congenital heart defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1983</id><symptom>constipation</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3204</id><symptom>corpus callosum, agenesis/hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>1782</id><symptom>epicanthus or medial eyelid fold</symptom><category>EYES</category></symtomp><symtomp><id>4025</id><symptom>excess digital whorls</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2319</id><symptom>genitalia, ambigous</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3342</id><symptom>hemangioma</symptom><category>SKIN</category></symtomp><symtomp><id>1960</id><symptom>hydrocephalus</symptom><category>HEAD | NERVOUS SYSTEM</category></symtomp><symtomp><id>2619</id><symptom>hydronephrosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2320</id><symptom>hypospadia</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2414</id><symptom>limb abnormalities, limb deformities / lower limb deformities</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2218</id><symptom>low set ears</symptom><category>EARS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2418</id><symptom>myelination, incomplete, hypomyelination</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2012</id><symptom>photophobia or photosensitive defect in light-exposed area</symptom><category>SKIN</category></symtomp><symtomp><id>2416</id><symptom>polydactyly</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>2688</id><symptom>pulmonary hypoplasia / lung hypoplasia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1993</id><symptom>pyloric stenosis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>4079</id><symptom>rhizomelia</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3439</id><symptom>sacral dimple</symptom><category>BODY</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1832</id><symptom>short neck</symptom><category>BODY</category></symtomp><symtomp><id>2412</id><symptom>short nose</symptom><category>HEAD</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3343</id><symptom>skin rash, eczematous or seborrhoic / skin rash</symptom><category>SKIN</category></symtomp><symtomp><id>1826</id><symptom>small chin or micrognathia</symptom><category>HEAD</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp><symtomp><id>2415</id><symptom>syndactyly / webbed toes</symptom><category>SKELETAL DEFECT | SKIN</category></symtomp><symtomp><id>2417</id><symptom>urinary tract defects</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2150</id><symptom>ventricular septal defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1576</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>3.40</min><max>9.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1709</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>17.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>2131</id><name>7-Dehydrocholesterol</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.01</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>984</id><name>17-Ketosteroids</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>14.00</max><unit>&#956;mol/24h</unit><age>child</age><method /><comment /></metabolite><metabolite><id>83</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1342</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1343</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1156</id><name>3-Methylglutaconic acid</name><specimen>amnion fluid</specimen><value>normal/inc</value><min>    </min><max>    </max><unit>no data</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>807</id><name>7-Dehydrocholesterol reductase</name><specimen>liver microsome</specimen><value>normal/inc</value><min>380.00</min><max>500.00</max><unit>pmol/mg protein/min</unit><age>child</age><method /><comment /></metabolite><metabolite><id>805</id><name>7-Dehydrocholesterol</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>not detected</unit><age>child</age><method /><comment /></metabolite><metabolite><id>806</id><name>8-Dehydrocholesterol</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.02</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4958</id><title>Smith-Lemli-Opitz Syndrome</title><author>Nowaczyk MJM</author><journal>GeneReviews&#174; [Internet]</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Wassif CA</co_aut></literature><literature><id>7978</id><title>Smith-Lemli-Opitz syndrome: what is the actual risk for couples carriers of the DHCR7:c.964-1G</title><author>Daum H,</author><journal>Eur J Hum Genet</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7359</id><title>Smith-Lemli-Opitz syndrome: clinical and biochemical correlates</title><author>Donoghue SE,</author><journal>J Pediatr Endocrinol Metab</journal><year>2018</year><book /><volume>31</volume><number>4</number><pages>451-459</pages><co_aut>et al.</co_aut></literature><literature><id>7361</id><title>Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention</title><author>Fliesler SJ,</author><journal>Molecules</journal><year>2018</year><book /><volume>23</volume><number>10</number><pages>E272</pages><co_aut>Xu L</co_aut></literature><literature><id>7360</id><title>Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates</title><author>Lazarin GA,</author><journal>Prenat Diagn</journal><year>2017</year><book /><volume>37</volume><number>4</number><pages>350-355</pages><co_aut>et al.</co_aut></literature><literature><id>7362</id><title>[Inborn error of cholesterol biosynthesis: Smith-Lemli-Opitz syndrome]</title><author>Koczok K,</author><journal>Orv Hetil</journal><year>2015</year><book /><volume>156</volume><number>42</number><pages>1695-1702</pages><co_aut>et al.</co_aut></literature><literature><id>4959</id><title>Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology</title><author>Nowaczyk MJ,</author><journal>Am J Med Genet C Semin Med Genet</journal><year>2012</year><book /><volume>160</volume><number>4</number><pages>250-262</pages><co_aut>Irons MB</co_aut></literature><literature><id>2720</id><title>Sacral dimple as a skin manifestation of the Smith-Lemli-Opitz syndrome</title><author>Bzduch V</author><journal>J Inher Met Dis</journal><year>2007</year><book /><volume>30</volume><number>0</number><pages>269-270</pages><co_aut>Behulova D, Kozak L</co_aut></literature><literature><id>2012</id><title>3beta-Hydroxysterol Delta(7)-reductase and the Smith-Lemli-Opitz syndrome</title><author>Correa-Cerro LS</author><journal>Mol Genet Metab</journal><year>2005</year><book /><volume>84</volume><number>2</number><pages>112-126</pages><co_aut>et al.</co_aut></literature><literature><id>2013</id><title>Characterization of liver involvement in defects of cholesterol biosynthesis: long-term follow-up and review</title><author>Rossi M</author><journal>Am J Med Genet A</journal><year>2005</year><book /><volume>132</volume><number>2</number><pages>144-151</pages><co_aut>et al.</co_aut></literature><literature><id>2014</id><title>Vitamin D status in patients affected by Smith-Lemli-Opitz syndrome</title><author>Rossi M</author><journal>J Inherit Metab Dis</journal><year>2005</year><book /><volume>28</volume><number>1</number><pages>69-80</pages><co_aut>et al.</co_aut></literature><literature><id>2015</id><title>DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome</title><author>Ciara E</author><journal>Clin Genet</journal><year>2004</year><book /><volume>66</volume><number>6</number><pages>517-524</pages><co_aut>et al.</co_aut></literature><literature><id>2016</id><title>Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers</title><author>Lalovic A</author><journal>Am J Psychiatry</journal><year>2004</year><book /><volume>161</volume><number>11</number><pages>2123-2126</pages><co_aut>et al.</co_aut></literature><literature><id>1188</id><title>Inherited disorders of cholesterol biosynthesis</title><author>Haas D</author><journal>Neuropediatrics</journal><year>2001</year><book /><volume>32</volume><number>0</number><pages>113-122</pages><co_aut>Kelley RI, Hoffmann GF</co_aut></literature><literature><id>1052</id><title>Mutational spectrum in the delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opit</title><author>Witsch-Baumgartner M</author><journal>Am J Hum Genet</journal><year>2000</year><book /><volume>66</volume><number>0</number><pages>402-412</pages><co_aut>et al.</co_aut></literature><literature><id>2011</id><title>Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome</title><author>Yu H</author><journal>Hum Mol Genet</journal><year>2000</year><book /><volume>9</volume><number>9</number><pages>1386-1391</pages><co_aut>et al.</co_aut></literature><literature><id>902</id><title>Disorders of cholesterol biosynthesis</title><author>Clayton PT</author><journal>Arch Dis Child</journal><year>1998</year><book /><volume>78</volume><number>0</number><pages>185-189</pages><co_aut>et al.</co_aut></literature><literature><id>822</id><title>Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome</title><author>Nwokoro NA</author><journal>Am J Med Genet</journal><year>1997</year><book /><volume>31</volume><number>0</number><pages>315-321</pages><co_aut>Mulvihill JJ</co_aut></literature><literature><id>129</id><title>Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome</title><author>Salen G</author><journal>J Inherit Metab Dis. 1996;19(4):391-400.</journal><year>1996</year><book /><volume>19</volume><number>4</number><pages>391-400</pages><co_aut>et al.</co_aut></literature><literature><id>424</id><title>Detection of defective 3&#223;-hydroxysterol delta7-reductase activity in cultured human fibroblasts: a method for the diagnosis of </title><author>Lund E</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>59-64</pages><co_aut>Starck L, Venizelos N</co_aut></literature><literature><id>130</id><title>Clinical features of the Smith-Lemli-Opitz syndrome and treatment of the cholesterol metabolic defect</title><author>Irons M</author><journal>International Pediatrics</journal><year>1995</year><book /><volume>10</volume><number>1</number><pages>28-32</pages><co_aut>Elias ER, Abuelo D, Tint S, Salen G</co_aut></literature><literature><id>314</id><title>3-methylglutaconic acidemia in Smith-Lemli-Opitz syndrome </title><author>Kelley RI</author><journal>Pediatr Res</journal><year>1995</year><book /><volume>37</volume><number>5</number><pages>671-674</pages><co_aut>Kratz L</co_aut></literature><literature><id>443</id><title>Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome</title><author>Tint GS</author><journal>J Pediatr</journal><year>1995</year><book /><volume>127</volume><number>0</number><pages>82-87</pages><co_aut>et al.</co_aut></literature><literature><id>132</id><title>Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome</title><author>Tint GS</author><journal>N Engl J Med</journal><year>1994</year><book /><volume>330</volume><number>0</number><pages>107-113</pages><co_aut>Irons M, Elias ER, et al.</co_aut></literature></Literatures></Disease>